Phenylephrine hypertrophy, Ca2+-ATPase (SERCA2), and Ca 2+ signaling in neonatal rat cardiac myocytes

American Journal of Physiology - Cell Physiology

Volumn 292, Issue 6, 2007, Pages

  Prasad, A M ^a   Ma, H ^b   Sumbilla, C ^b   Lee, D I ^b   Klein, M G ^b   Inesi, G ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium adenosinetriphosphatase; Calcium transport

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ATRIAL NATRIURETIC FACTOR; CALCIUM ION; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PHENYLEPHRINE; SMALL INTERFERING RNA; THAPSIGARGIN; ATP2A2 PROTEIN, RAT; CARDIOTONIC AGENT; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL SIZE; CONTROLLED STUDY; DOWN REGULATION; ELECTROSTIMULATION; ENDOPLASMIC RETICULUM; HEART MUSCLE CELL; HEART SIZE; HEART VENTRICLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM; TRANSCRIPTION INITIATION; ANIMAL; CARDIOMEGALY; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CYTOSOL; DOSE RESPONSE; GENE EXPRESSION REGULATION; GENE SILENCING; METABOLISM; NEWBORN; TIME;

RATTUS;

ANIMALS; ANIMALS, NEWBORN; CALCIUM SIGNALING; CARDIOMEGALY; CARDIOTONIC AGENTS; CELLS, CULTURED; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE SILENCING; MYOCYTES, CARDIAC; PHENYLEPHRINE; RATS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; THAPSIGARGIN; TIME FACTORS;

EID: 34447532026     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00441.2006     Document Type: Article

References (38)

1. Arai M, Alpert NR, MacLennan DH, Barton P, Periasami M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 72: 463-469, 1993.
2. 2+ transport. Circ Res 93: 487-490, 2003.
3. 2+ transients of embryonic chicken and neonatal rat cardiac myocytes. J Physiol 528: 53-63, 2000.
4. Chien KR. Meeting Koch's postulates for calcium signaling in cardiac hypertrophy. J Clin Invest 105: 1339-1342, 2000.
5. Del Monte F, Hajjar RJ. Targeting calcium cycling proteins in heart failure through gene transfer. J Physiol 546: 49-61, 2003.
6. 2+-ATPase in a rat model of heart failure. Circulation 104: 1424-1429, 2001.
7. Deng XF, Rokosh DG, Simpson PC. Autonomous and growth factor-induced hypertrophy in cultured neonatal mouse cardiac myocytes. Comparison with rat. Circ Res 87: 781-788, 2000.
8. 2+ ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy. J Mol Med 74: 321-332, 1996.
9. Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65: 45-79, 2003.
10. 2+ transients. Circulation 96: 400-403, 1997.
11. Hanford DS, Thuerauf DJ, Murray SF, Glembotski CC. Brain natriuretic peptide is induced by alpha 1-adrenergic agonists as a primary response gene in cultured rat cardiac myocytes. J Biol Chem 269: 26227-26233, 1994.
12. Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML. Construction of adenovirus vectors through Cre-lox recombination. J Virol 71: 1842-1849, 1997.
13. Hasenfuss G, Meyer M, Schillinger W, Preuss M, Pieske B, Just H. Calcium handling proteins in the failing human heart. Basic Res Cardiol 92: 87-93, 1997.
14. 2+ ATPase in failing and nonfailing human myocardium. Circ Res 75: 434-442, 1994.
15. 2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J Clin Invest 100: 380-389, 1997.
16. Inesi G, Lewis D, Sumbilla C, Nandi A, Strock C, Huff KW, Rogers TB, Johns DC, Kessler PD, Ordahl CP. Cell-specific promoter in adenovirus vector for transgenic expression of SERCA1 ATPase in cardiac myocytes. Am J Physiol Cell Physiol 274: C645-C653, 1998.
17. Jeong MY, Kinugawa K, Vinson C, Long CS. AFos dissociates cardiac myocyte hypertrophy and expression of the pathological gene program. Circulation 111: 1645-1651, 2005.
18. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
19. Lehnart SE, Schillinger W, Pieske B, Prestle J, Just H, Hasenfuss G. Sarcoplasmic reticulum proteins in heart failure. Ann NY Acad Sci 853: 220-230, 1998.
20. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322: 1561-1566, 1990.
21. 2+-ATPase. Circ Res 83: 889-897, 1998.
22. 2+ transport ATPase, in cardiac myocytes. Am J Physiol Cell Physiol 286: C556-C564, 2004.
23. 2+ ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest 85: 305-309, 1990.
24. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just H, Hesenfuss G. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92: 778-784, 1995.
25. Miyamoto MI, del Monte F, Schmidt U, DiSalvo TS, Kang ZB, Matsui T, Guerrero JL, Gwathmey JK, Rosenzweig A, Hajjar RJ. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci USA 97: 793-798, 2000.
26. 2+ transporting ATPase, phospholamban and calsequestrin levels in nonfailing and failing human myocardium. Circulation 90: 653-657, 1994.
27. O'Donnell JM, Sumbilla CM, Ma H, Farrance IK, Cavagna M, Klein MG, Inesi G. Tight control of exogenous SERCA expression is required to obtain acceleration of calcium transients with minimal cytotoxic effects in cardiac myocytes. Circ Res 88: 415-421, 2001.
28. Okayama H, Hamada M, Kawakami H, Ikeda S, Hashida H, Shigematsu Y, Hiwada K. Alterations in expression of sarcoplasmic reticulum gene in Dahl rats during the transition from compensatory myocardial hypertrophy to heart failure. J Hypertens 15:1767-1774, 1997.
29. 2+ load in human heart failure. Basic Res Cardiol 97, Suppl 1: I63-I71, 2002.
30. Sadoshima J, Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol 59: 551-571, 1997.
31. Schultz JJ, Glascock BJ, Witt SA, Nieman ML, Nattamai KJ, Liu LH, Lorenz JN, Shull GE, Kimball TR, Periasamy M. Accelerated onset of heart failure in mice during pressure overload with chronically decreased SERCA2 calcium pump activity. Am J Physiol Heart Circ Physiol 286: H1146-H1153, 2004.
32. 2+ ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation: 92: 3220-3228, 1995.
33. Simpson PC. Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1- and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating. Circ Res 56: 884-894, 1985.
34. Simpson P, McGrath A, Savion S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res 51: 787-801, 1982.
35. Sumbilla C, Cavagna M, Zhong L, Ma H, Lewis D, Farrance I, Inesi G. Comparison of SERCA1 and SERCA2a expressed in COS-1 cells and cardiac myocytes. Am J Physiol Heart Circ Physiol 277: H2381-H2391, 1999.
36. Wright G, Singh IS, Hasday JD, Farrance IK, Hall G, Cross AS, Rogers TB. Endotoxin stress-response in cardiomyocytes: NF-κB activation and tumor necrosis factor-α expression. Am J Physiol Heart Circ Physiol 282: H872-H879, 2002.
37. Yue P, Long CS, Austin R, Chang KC, Simpson PC, Massie BM. Post-infarction heart failure in the rat is associated with distinct alterations in cardiac myocyte molecular phenotype. J Mol Cell Cardiol 30: 1615-1630, 1998.
38. Zheng M, Dilly K, Dos Santos CJ, Li M, Gu Y, Ursitti JA, Chen J, Ross J Jr, Chien KR, Lederer JW, Wang Y. Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart. Am J Physiol Heart Circ Physiol 286: H424-H433, 2004.